Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

Ulcerative colitis in smokers, non-smokers and ex-smokers

(2016) Guillermo Bastida   WORLD JOURNAL OF GASTROENTEROLOGY

C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

(2015) Mahmoud H Mosli et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis

(2015) Klaus Theede et al.   Clinical Gastroenterology and Hepatology

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients

(2015) Klaus Theede et al.   Journal of Crohns & Colitis

Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission

(2014) Jordi Guardiola et al.   Clinical Gastroenterology and Hepatology

Histologic Evaluation of Ulcerative Colitis

(2014) Mahmoud H. Mosli et al.   INFLAMMATORY BOWEL DISEASES

The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment

(2014) Klaus Theede et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors

(2013) Claudio Papi et al.   DIGESTIVE AND LIVER DISEASE

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

(2013) Martine De Vos et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy

(2013) Takayuki Yamamoto et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

(2012) Talat Bessissow et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Faecal markers of gastrointestinal inflammation

(2012) Roy A Sherwood   JOURNAL OF CLINICAL PATHOLOGY

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

(2011) Sandro Ardizzone et al.   Clinical Gastroenterology and Hepatology

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation

(2011) Judith E. Baars et al.   INFLAMMATORY BOWEL DISEASES

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

(2011) M. De Vos et al.   Journal of Crohns & Colitis

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis